Ozlem Baykara Sengül1, Tamer Mungan2, Evrim Erdemoğlu2, Göksel Islamoğlu1, Nuran Kıyak1. 1. Department of Obstetrics and Gynecology, Zekai Tahir Burak Womens Health Hospital, Ankara, Turkey. 2. Department of Obstetrics and Gynecology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
Abstract
OBJECTIVE: To investigate the correlation between maternal leptin levels and 100 gram oral glucose test (OGTT) results as well as the correlation between leptin levels and the development of gestational diabetes mellitus (GDM) and glucose intolerance during pregnancy. MATERIAL AND METHOD: 104 subjects with gestational weeks ranging from 24 to 32 weeks who had increased 50 gr OGTT values (>140) were included in this study. After the screening test, 100 gr OGTT was administered to the subjects. Sixty cases were selected from these subjects; twenty patients with one abnormal test result were identified as "glucose intolerant" group (Group 1), 20 patients with two abnormal test values were diagnosed with GDM (Group 2) and 20 patients with normal test results constituted the control group. The serum leptin levels of the groups were measured with enzyme linked immunosorbent assay (ELISA). RESULTS: The serum leptin level was 8.4±5.1 ng/ml for group 1, 9.1±5.3 ng/ml for group 2 and 6.3±4.6 ng/ml for the control group. Although serum leptin levels for group 1 and 2 was observed to be higher than the control group, the result was not statistically significant (p>0.05). This result did not change after adjusting for body mass index (BMI). CONCLUSION: There is no statistically significant difference between leptin levels among three groups.
OBJECTIVE: To investigate the correlation between maternal leptin levels and 100 gram oral glucose test (OGTT) results as well as the correlation between leptin levels and the development of gestational diabetes mellitus (GDM) and glucose intolerance during pregnancy. MATERIAL AND METHOD: 104 subjects with gestational weeks ranging from 24 to 32 weeks who had increased 50 gr OGTT values (>140) were included in this study. After the screening test, 100 gr OGTT was administered to the subjects. Sixty cases were selected from these subjects; twenty patients with one abnormal test result were identified as "glucose intolerant" group (Group 1), 20 patients with two abnormal test values were diagnosed with GDM (Group 2) and 20 patients with normal test results constituted the control group. The serum leptin levels of the groups were measured with enzyme linked immunosorbent assay (ELISA). RESULTS: The serum leptin level was 8.4±5.1 ng/ml for group 1, 9.1±5.3 ng/ml for group 2 and 6.3±4.6 ng/ml for the control group. Although serum leptin levels for group 1 and 2 was observed to be higher than the control group, the result was not statistically significant (p>0.05). This result did not change after adjusting for body mass index (BMI). CONCLUSION: There is no statistically significant difference between leptin levels among three groups.
Entities:
Keywords:
Gestational Diabetes Mellitus; Leptin; Oral Glucose Tolerance Test
Authors: M F Saad; A Khan; A Sharma; R Michael; M G Riad-Gabriel; R Boyadjian; S D Jinagouda; G M Steil; V Kamdar Journal: Diabetes Date: 1998-04 Impact factor: 9.461
Authors: G P McGregor; J F Desaga; K Ehlenz; A Fischer; F Heese; A Hegele; C Lammer; C Peiser; R E Lang Journal: Endocrinology Date: 1996-04 Impact factor: 4.736
Authors: M Martha Vela-Huerta; Edgar Ulises San Vicente-Santoscoy; Juan Manuel Guizar-Mendoza; Norma Amador-Licona; Carlos Aldana-Valenzuela; Javier Hernnández Journal: J Pediatr Endocrinol Metab Date: 2008-01 Impact factor: 1.634
Authors: M Maffei; J Halaas; E Ravussin; R E Pratley; G H Lee; Y Zhang; H Fei; S Kim; R Lallone; S Ranganathan Journal: Nat Med Date: 1995-11 Impact factor: 53.440
Authors: R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer Journal: N Engl J Med Date: 1996-02-01 Impact factor: 91.245